Compounding for Pain Management—How to turn Turmoil into Opportunity
Sponsored by Medisca, Inc.

Saturday, October 10, 2015, 1:30 p.m. - 3:00 p.m.
Gaylord National Resort and Convention Center
Continuing Education Credits: 0.15 (1.5 Contact Hours)
ACPE #: 207-000-15-105-L04-P and ACPE #: 207-000-15-105-L04-T

The compounded pain market has been through a rollercoaster ride during its history; beginning as a virtually unknown therapeutic option to pharmacists and prescribers 15 years ago, to a peak at the end of last year, to its slow descent today. Is the market descent due to lack of efficacy or safety? Or is it due to payer changes in response to the need to control costs or for other reasons? Regardless of the causality of the drop, opportunities for compounders, prescribers and, certainly, the patients they serve still exist.

Pharmacist and Pharmacy Technician Learning Objectives:

  1. Discuss novel "targeted" approaches for the treatment of pain.
  2. Describe a multi-modal approach to pharmacotherapeutics to intercept deleterious afferent pain signal elicitation and subsequent excitation, inhibition, cessation and modulation though compounded analgesic therapy.
  3. Highlight select pharmacodynamic differences within specific chemical classifications that will allow the compounding specialist to individualize pharmacotherapy, not only on patient parameters but also on known chemical activities.
  4. Discuss ideas about how to differentiate your compounding practice in order to sustain compounding for pain management as a viable niche offering.
  5. Describe how the recent changes in third party reimbursement have affected patient access and suggest potential strategies to counter patient access challenges.

Speaker: Ken Speidel, RPh, BS Pharm, PharmD, Gates Healthcare Associates, Ravenna, Ohio

Activity Type: Application-based
Audience: Pharmacists and Pharmacy Technicians